Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 12
Submit an article Journal homepage
755
Views
3
CrossRef citations to date
0
Altmetric
Diabetes

iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents

Neil SkolnikAbington Family Medicine, Jenkintown, PA, USA; ;Abington Jefferson Health, Jenkintown, PA, USA; Correspondence[email protected]
,
Renell S. DupreeAbington Jefferson Health, Jenkintown, PA, USA;
&
Eric L. JohnsonUniversity of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA
Pages 2187-2194 | Received 17 Mar 2017, Accepted 10 Jul 2017, Published online: 04 Aug 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.